Millennium Management
BNTX icon

Millennium Management’s BioNTech BNTX Stock Holding History

Millennium Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.14M Sell
35,372
-236,993
-87% -$24.4M ﹤0.01% 3430
2025
Q4 		$25.9M Buy
272,365
+26,038
+11% +$2.62M 0.01% 1325
2025
Q3 		$24.3M Buy
+246,327
New +$26.3M 0.01% 1465
2025
Q2 		– Sell
-544,970
Closed -$55M – 5876
2025
Q1 		$49.6M Buy
544,970
+373,660
+218% +$41.8M 0.03% 775
2024
Q4 		$19.5M Buy
171,310
+147,215
+611% +$16.8M 0.01% 1544
2024
Q3 		$2.86M Sell
24,095
-630,021
-96% -$57.9M ﹤0.01% 3359
2024
Q2 		$52.6M Buy
654,116
+466,472
+249% +$42.6M 0.02% 759
2024
Q1 		$17.3M Buy
187,644
+21,691
+13% +$2.08M 0.01% 1680
2023
Q4 		$17.5M Sell
165,953
-332,448
-67% -$33.5M 0.01% 1649
2023
Q3 		$54.1M Buy
498,401
+147,391
+42% +$16.3M 0.03% 652
2023
Q2 		$37.9M Sell
351,010
-119,866
-25% -$13.5M 0.02% 922
2023
Q1 		$58.7M Buy
470,876
+348,853
+286% +$47.9M 0.03% 597
2022
Q4 		$18.3M Buy
122,023
+35,738
+41% +$5.5M 0.01% 1527
2022
Q3 		$11.6M Sell
86,285
-330,028
-79% -$50.5M 0.01% 1947
2022
Q2 		$62.1M Buy
416,313
+154,877
+59% +$23.7M 0.04% 527
2022
Q1 		$44.6M Buy
261,436
+240,607
+1,155% +$40.4M 0.02% 762
2021
Q4 		$5.37M Sell
20,829
-289,001
-93% -$79.2M ﹤0.01% 2831
2021
Q3 		$84.6M Buy
309,830
+73,611
+31% +$23.4M 0.05% 383
2021
Q2 		$52.9M Buy
236,219
+143,690
+155% +$27.1M 0.03% 575
2021
Q1 		$10.1M Sell
92,529
-96,537
-51% -$10.3M 0.01% 1758
2020
Q4 		$15.4M Sell
189,066
-78,664
-29% -$7.72M 0.01% 1291
2020
Q3 		$18.5K Buy
267,730
+99,632
+59% +$7.15M 0.02% 838
2020
Q2 		$11.2M Buy
168,098
+160,425
+2,091% +$8.01M 0.02% 1136
2020
Q1 		$448K Sell
7,673
-132,532
-95% -$5.16M ﹤0.01% 2958
2019
Q4 		$4.75M Buy
+140,205
New +$3.14M 0.01% 1980

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management's BNTX Position: Q1 2026 in Review

Millennium Management reduced its BioNTech (BNTX) stake by 87% in Q1 2026, selling an estimated $24.4M and leaving 35,372 shares worth $3.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3430.

Millennium Management first reported a position in BNTX in Q4 2019 and has held it in 25 quarters since. The position peaked at $84.6M in Q3 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Millennium Management held 35,372 shares of BioNTech worth $3.14M as of Q1 2026.
  • Millennium Management sold 236,993 BioNTech shares in Q1 2026, an estimated $24.4M.
  • BioNTech made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3430 holding.
  • Millennium Management first reported a position in BioNTech in Q4 2019 and has held it in 25 quarters since.
  • Millennium Management's BioNTech position peaked at $84.6M in Q3 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.